|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/485 | |||
| A61K 9/24 |
| (11) | Number of the document | 1931315 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06789964.1 |
| Date of filing the European patent application | 2006-08-24 | |
| (97) | Date of publication of the European application | 2008-06-18 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/033011 |
| Date | 2006-08-24 |
| (87) | Number | WO 2007/025005 |
| Date | 2007-03-01 |
| (30) | Number | Date | Country code |
| 710772 P | 2005-08-24 | US | |
| 772466 P | 2006-02-10 | US |
| (72) |
BAICHWAL, Anand, R., US
GOLIBER, Philip, A., US
CARPANZANO, Anthony, E., US
SCIASCIA, Thomas, US
DIEHL, Donald, II, US
VOGLER, Brian, US
|
| (73) |
Endo Pharmaceuticals Inc.,
1400 Atwater Drive, Malvern, PA 19355,
US
|
| (54) | SUSTAINED RELEASE FORMULATIONS OF NALBUPHINE |
| SUSTAINED RELEASE FORMULATIONS OF NALBUPHINE |